These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 55112)

  • 41. [Fluorescence of urinary sediment following administration of rondomycin in women with genital neoplasms].
    Lipska-Rodziewicz T; Radomański T
    Wiad Lek; 1971 Jun; 24(12):1159-62. PubMed ID: 5561271
    [No Abstract]   [Full Text] [Related]  

  • 42. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Our experience of chemotherapy preparatory to radical treatment (radiotherapy and surgery) of epitheliomas in the upper aerodigestive passage at an advanced stage of development (proceedings)].
    Caudry M; Pinsolle J; Dilhuydy JM; Michelet FX; Reboul J
    J Radiol Electrol Med Nucl; 1978 Nov; 59(11):632-3. PubMed ID: 85708
    [No Abstract]   [Full Text] [Related]  

  • 44. [Cytologic urine findings in female genital cancer--before, during and after radiotherapy].
    Hoppe E; Schicke B; Banaschak A
    Zentralbl Gynakol; 1988; 110(7):450-60. PubMed ID: 3394442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [On the action of cyclophosphamide at the level of normal bladder mucosa in patients with genital neoplasms (cytological research)].
    FONTANA DONATELLI G; PASQUINUCCI C
    Ann Ostet Ginecol; 1962 Nov; 84():954-66. PubMed ID: 13963069
    [No Abstract]   [Full Text] [Related]  

  • 46. [A model for gynecologic tumor therapy].
    Brody S; Gemzell C
    Lakartidningen; 1969 Jul; 66(27):2751-4. PubMed ID: 5804633
    [No Abstract]   [Full Text] [Related]  

  • 47. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
    Avilés A; García EL; Fernández R; Gonzalez JL; Neri N; Díaz-Maqueo JC
    Ann Hematol; 2002 Jul; 81(7):368-73. PubMed ID: 12185505
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.
    Chambers SK; Flynn SD; Del Prete SA; Chambers JT; Schwartz PE
    Gynecol Oncol; 1989 Mar; 32(3):303-9. PubMed ID: 2465939
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of 6,17 alpha-dimethyl-6-dehydroprogesterone for treatment of recurrent and metastatic gynecologic malignancy.
    Malkasian GD; Decker DG; Jorgensen EO; Webb MJ
    Am J Obstet Gynecol; 1974 Feb; 118(4):461-5. PubMed ID: 4591115
    [No Abstract]   [Full Text] [Related]  

  • 50. [Differential diagnostic value of urine cytology in gynecologic neoplasms].
    Breinl H; Dehnhard F
    Arch Gynakol; 1975 Nov; 219(1-4):69-70. PubMed ID: 1243515
    [No Abstract]   [Full Text] [Related]  

  • 51. Combination chemotherapy with vincristine, carmustine, carmustine (BCNU), and bleomycin in patients with squamous cell bronchial carcinoma resistant to cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Veronesi A; Magri MD; Trovò MG; Tirelli U; Galligioni E; Tumolo S; Grigoletto E
    Cancer Treat Rep; 1982 Oct; 66(10):1877-8. PubMed ID: 6181871
    [No Abstract]   [Full Text] [Related]  

  • 52. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

  • 53. Advances in the use of radiation for gynecologic cancers.
    Viswanathan AN
    Hematol Oncol Clin North Am; 2012 Feb; 26(1):157-68. PubMed ID: 22244667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The clinical significance of calculated versus measured creatinine clearance in patients with gynecologic malignancy.
    Rao PS; Fiorica JV; Shah RP; Graham L; Roberts WS; Hoffman MS; Cavanagh D
    South Med J; 1996 Oct; 89(10):967-70. PubMed ID: 8865788
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: results of a prospective, multicenter study of the Gruppo Italiano Per Lo Studio Dei Linfomi (GISL).
    Lombardo M; Morabito F; Merli F; Molica S; Cavanna L; Sacchi S; Broglia C; Angrilli F; Ilariucci F; Stelitano C; Luisi D; Bertè R; Luminari S; Federico M; Brugiatelli M;
    Leuk Lymphoma; 2002 Sep; 43(9):1795-801. PubMed ID: 12685834
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bleomycin combination chemotherapy in the management of testicular neoplasia.
    Samuels ML; Holoye PY; Johnson DE
    Cancer; 1975 Aug; 36(2):318-26. PubMed ID: 50869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ifosfamide in the management of gynecologic cancers.
    Thigpen T; Lambuth BW; Vance RB
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):11-8. PubMed ID: 2185545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Histoautoradiographic examinations of benign and malignant cells and tissues during therapeutic interventions in gynecology].
    Kaltenbach FJ
    Fortschr Med; 1977 Jun; 95(22):1450-5. PubMed ID: 68902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Future directions in gynecologic cancer.
    Alberts DS
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):125-8. PubMed ID: 10348271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unreliability of urinary cytology in detecting gynecologic malignancy.
    Creasman WT; Lukeman J
    Cancer; 1972 Jul; 30(1):148-9. PubMed ID: 5040737
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.